![Julie DiCarlo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie DiCarlo
Geen lopende functies
Loopbaan van Julie DiCarlo
Eerdere bekende functies van Julie DiCarlo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AKILI, INC. | Public Communications Contact | 01-09-2019 | - |
PURETECH HEALTH PLC | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
EPIZYME, INC. | Investor Relations Contact | 02-08-2016 | - |
Public Communications Contact | 02-08-2016 | - | |
CUBIST PHARMACEUTICALS INC | Public Communications Contact | - | - |
Opleiding van Julie DiCarlo
Towson University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Public Communications Contact | 4 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PURETECH HEALTH PLC | Health Technology |
AKILI, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Epizyme, Inc.
![]() Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Julie DiCarlo
- Ervaring